Literature DB >> 3930280

Unity of costal and crural diaphragmatic activity in respiration.

M J Pollard, D Megirian, J H Sherrey.   

Abstract

In chronically implanted rats, we examined the respiratory EMG activity of the two parts of the diaphragm, costal and crural, during sleep and wakefulness. Their activity was compared and contrasted with that of the EMG activity of the cricothyroid muscle. Whether in wakefulness, while grooming and drinking, or in nonrapid eye movement (non-REM) sleep, and independent of the gas mixture breathed (4 to 5% CO2 or 10% O2 in nitrogen), the two parts of the diaphragm paused during REM apnea episodes whereas the cricothyroid muscle ceased its activity or exhibited sustained activity. We conclude that the diaphragm, mainly an inspiratory muscle, acts as a single functional unit when under the respiratory control system. The cricothyroid muscle functions as an inspiratory and/or expiratory muscle, also under the respiratory control systems. Both muscles in the rat come under other neural control mechanisms governing nonrespiratory functions, e.g., swallowing, defecation, and coughing, but not vomiting.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3930280     DOI: 10.1016/0014-4886(85)90051-2

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  3 in total

1.  Role of medullary inspiratory neurones in the control of the diaphragm during oesophageal stimulation in cats.

Authors:  S M Altschuler; R O Davies; A I Pack
Journal:  J Physiol       Date:  1987-10       Impact factor: 5.182

Review 2.  The diaphragm: two physiological muscles in one.

Authors:  Mark Pickering; James F X Jones
Journal:  J Anat       Date:  2002-10       Impact factor: 2.610

3.  Chronic intrinsic transient tracheal occlusion elicits diaphragmatic muscle fiber remodeling in conscious rodents.

Authors:  Barbara K Smith; A Daniel Martin; Krista Vandenborne; Brittany D Darragh; Paul W Davenport
Journal:  PLoS One       Date:  2012-11-01       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.